Articles

De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways

Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Center for Cancer Biology, SA Pathology, Adelaide, Australia
Center for Cancer Biology, SA Pathology, Adelaide, Australia
Center for Cancer Biology, SA Pathology, Adelaide, Australia;University of Adelaide, South Australia, Australia
GalSeq s.r.l., Monza, Italy
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Center for Cancer Biology, SA Pathology, Adelaide, Australia
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Department of Bioscience and Biotechnology, University of Milano Bicocca, Milano, Italy
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Bloodwise Molecular Haematology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK;NIHR Biomedical Research Centre, Oxford, UK
Department of Clinical and Biological Sciences, San Luigi Hospital, University of Turin, Turin, Italy
Department of Clinical and Biological Sciences, San Luigi Hospital, University of Turin, Turin, Italy
Department of Hematology, Catholic University, Seoul, South Korea
Center for Cancer Biology, SA Pathology, Adelaide, Australia;University of Adelaide, South Australia, Australia;University of South Australia, Adelaide, South Australia, Australia
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy;Hematology and Clinical Research Unit, San Gerardo Hospital, Monza, Italy
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
Vol. 104 No. 9 (2019): September, 2019 https://doi.org/10.3324/haematol.2017.179937